Renal Pelvis Squamous Cell Carcinoma Arising in the Setting of Long-Standing Nephrolithiasis: Clinicopathologic and Molecular Insights.

Int J Surg PatholJun 3, 2026 (epub)

Ahmet Erbağci, Sıdıka Şeyma Özkanli, Sevil Albayrak et al.

✦ AI-curated · Sources linked

Case in brief

Two patients with decades-long renal stone disease developed squamous cell carcinoma of the renal pelvis. Both tumors showed extensive squamous metaplasia, moderately differentiated carcinoma with comedo-type necrosis, and aggressive local invasion; clinical outcomes were poor. Immunohistochemistry showed diffuse p63, p40, and keratin 5/6 expression, aberrant p53 patterns, p16 negativity, and high PD-L1 expression (CPS 85 and 72.5). Both tumors had TP53 alterations; one also had a TERT promoter mutation (C228T) and was associated with early distant metastases.

What made this case unusual

Both tumors had strikingly high PD-L1 expression, and one carried a TERT promoter mutation associated with early distant metastases.

Diagnostic / clinical pearl

In renal pelvis tumors arising with long-standing nephrolithiasis, extensive squamous metaplasia and a squamous immunophenotype can support recognition of SCC; the reported tumors also showed aggressive invasion and poor outcomes.

Why it matters

The authors suggest that PD-L1 expression may be relevant to immune checkpoint inhibition, although these two cases do not establish treatment benefit.

Source

Published in Int J Surg Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.